Literature DB >> 5676087

[Adrenocortical insufficiency associated with a non-secreting adrenocortical carcinoma].

A Demaret, N Cojocaru, J Brunet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5676087      PMCID: PMC1924423     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA.

Authors:  M B LIPSETT; R HERTZ; G T ROSS
Journal:  Am J Med       Date:  1963-09       Impact factor: 4.965

2.  Steroid metabolites from cholesterol-C14 in a patient with adrenal cancer: effects of metopirone.

Authors:  J SAROFF; W R SLAUNWHITE; G COSTA; A A SANDBERG
Journal:  J Clin Endocrinol Metab       Date:  1963-07       Impact factor: 5.958

3.  Excretion of pregnan-3 alpha, 17 alpha, 21-triol-20-one (tetrahydro S) by patients with adrenocortical carcinoma.

Authors:  M B LIPSETT; B DAMAST
Journal:  Proc Soc Exp Biol Med       Date:  1958-11

4.  Nonfunctioning carcinoma of the adrenal cortex.

Authors:  C D KNIGHT; B E TRICHEL; W R MATHEWS
Journal:  Ann Surg       Date:  1960-03       Impact factor: 12.969

5.  Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases.

Authors:  D A MACFARLANE
Journal:  Ann R Coll Surg Engl       Date:  1958-09       Impact factor: 1.891

6.  Adrenocortical cancer: steroid biosynthesis and metabolism evaluated by urinary metabolites.

Authors:  M B LIPSETT; H WILSON
Journal:  J Clin Endocrinol Metab       Date:  1962-09       Impact factor: 5.958

7.  Mortality in surgically treated adrenocortical tumors. II. Review of cases reported for the 20 year period 1930-1949, inclusive.

Authors:  E RAPAPORT; M B GOLDBERG; G S GORDAN; F HINMAN
Journal:  Postgrad Med       Date:  1952-04       Impact factor: 3.840

8.  Adrenal cortical carcinoma. Clinical features of 138 patients.

Authors:  A M Hutter; D E Kayhoe
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.